Is a complete EWTX research report available?

No complete published report is available for Edgewise Therapeutics, Inc. (EWTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · USD

$39.8

-0.60 (-1.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first EWTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	4.3B
Net income (ttm)	-176M
EPS (ttm)	-$1.66
Shares out	107.6M
Volume	698,413
Beta	0.28
Price target	$49.9	+25.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -176M
EPS (ttm): -$1.66
Market cap: 4.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All EWTX indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001710072
Company name	Edgewise Therapeutics, Inc.
Country	United States
Country code	US
Cusip	28036F105
Employees	154
Employees Change	8%
Employees Change Percent	5.48
Enterprise value	$3.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-03-26
Isin	US28036F1057
Last refreshed	2026-07-30
Market cap	$4.3B
Market cap category	Mid-Cap
Price	$39.75
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	EWTX
Website	https://edgewisetx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.11%
EV Sales Forward	20.34x
FCF yield	-3.48%
P/B ratio	8.79x
PS Forward	23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-176M
Net Income Growth Years	0%
Profit Per Employee	$-1.1M
ROA	-25.64
Roa5y	-18.79
ROCE	-40.24
ROE	-38.14
Roe5y	-28.36
ROIC	-26.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	178.95%
Cagr3y	78.21%
Cagr5y	15.05%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$518.5M
Cash	$499.6M
Current Assets	$509.8M
Current Liabilities	$22.5M
Debt	$3.8M
Debt Equity	$0.01
Equity	$493.2M
Liabilities	$25.3M
Long Term Assets	$8.7M
Long Term Liabilities	$2.8M
Net Cash	$495.8M
Net Cash By Market Cap	$11.58
Net Cash Growth	14.81%
Net Debt Equity	$-1.01
Tangible Book Value	$493.2M
Tangible Book Value Per Share	$4.59
WACC	5.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.61
Net Working Capital	$-11.3M
Quick ratio	22.16
Working Capital	$487.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.32%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	178.75%
200-day SMA	29.47
3Y total return	466.24%
50-day SMA	37.93
50-day SMA vs 200-day SMA	50over200
5Y total return	101.57%
All Time High	48.4
All Time High Change	-17.87%
All Time High Date	2026-07-09
All Time Low	5.12
All Time Low Change	676.37%
All Time Low Date	2023-11-10
ATR	2.4
Beta	0.28
Beta1y	0.67
Beta2y	1.97
Ch YTD	60.19
High	40.78
High52	48.4
High52 Date	2026-07-09
High52ch	-17.87%
Low	38.92
Low52	12.3
Low52 Date	2025-08-11
Low52ch	223.17%
Ma50ch	4.8%
Premarket Change Percent	0.57
Premarket Price	$40.58
Premarket Volume	6,175
Price vs 200-day SMA	34.89%
RSI	49.85
RSI Monthly	71.46
RSI Weekly	61.46
Sharpe ratio	1.66x
Sortino ratio	3.22
Total Return	-12.32%
Tr YTD	60.19
Tr1m	-4.12%
Tr1w	3.71%
Tr3m	28.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	11
Analyst Price Target Top	$51.6
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.48
Operating Income	$-199.6M
Price target	$49.92
Price Target Change	$25.59
Price Target Change Top	$29.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,119,763%
Float Percent	62.38%
Shares Insiders	0.54%
Shares Institutions	74.93%
Shares Out	107,593,006
Shares Qo Q	1.04%
Shares Yo Y	12.32%
Short Float	15.01%
Short Ratio	6.06
Short Shares	9.36

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-183.4M
Adjusted OCF	-182,901,000
Average Volume	996,576x
Bv Per Share	4.59
CAPEX	$-472,000
Ch1m	-4.12
Ch1w	3.71
Ch1y	178.8
Ch3m	28.27
Ch3y	466.2
Ch5y	101.6
Ch6m	38.6
Change	-1.49%
Change From Open	-1.46
Close	40.35
Days Gap	-0.02
Depreciation Amortization	2,108,000
Dollar Volume	27,761,916.8
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-199.6M
EBITDA	$-197.3M
EPS	$-1.66
F Score	2
FCF	$-149M
FCF EV Yield	-3.94x
FCF Per Share	$-1.38
Financing CF	206,038,000
Fiscal Year End	December
Founded	2,017
Investing CF	-74,255,000
Ipr	148.7
Iprfo	47.37
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	32.58
Ma150ch	22%
Ma20	41.02
Ma20ch	-3.09%
Net CF	-16,710,000
Next Earnings Date	2026-08-10
Open	40.34
Optionable	Yes
Position In Range	44.62
Post Close	39.75
Postmarket Change Percent	0.45
Postmarket Price	$39.93
Ppne	8,730,000
Pre Close	40.35
Price Date	2026-07-29
Ptbv Ratio	8.68
Relative Volume	0.7x
Share Based Comp	34,408,000
Tr6m	38.6%
Us State	Colorado
Volume	698,413

Edgewise Therapeutics, Inc. (EWTX)

Coverage state: Market snapshot only — no published research

Generate the first EWTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · EWTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EWTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on EWTX

Frequently asked questions